Brief e-cigarette use causes lasting lung damage and weakens viral defenses, study finds

A study led by National Jewish Health researchers and published in JCI Insight in October 2026 reveals that even brief exposure to e-cigarette vapor can cause lasting damage to the distal lung. In preclinical models, just five days of exposure triggered cellular stress, damaged protective barriers, and suppressed Th1 immunity for up to 10 days post-exposure. Additionally, prior vaping increased SARS-CoV-2 viral burden and weakened antiviral genes, highlighting heightened susceptibility to respiratory infections.

Impact on lung tissue and cells

• ▪In preclinical models, exposure to e-cigarette vapor damaged the protective barrier of distal lung cells and triggered cellular stress within 24 hours.
• ▪An October 2026 National Jewish Health study found that a five-day e-cigarette vapor exposure caused lasting damage, with lung stress persisting for 10 days in distal lung tissues of preclinical models.
• ▪E-cigarette vapor exposure in preclinical models impaired the internal clearing of damaged cell components, slowed cell growth and repair, and increased cell death.

Impaired immune response to viruses

• ▪Preclinical models exposed to e-cigarette vapor showed an increased SARS-CoV-2 viral burden and the suppression of several antiviral genes following infection.
• ▪Pulmonologist Irina Petrache stated that short-term e-cigarette exposure alters the immune response to subsequent viral infections, potentially contributing to chronic lung disease.
• ▪A National Jewish Health study in JCI Insight showed that a five-day e-cigarette vapor exposure caused lasting changes in Th1 immunity, weakening antiviral defenses and increasing susceptibility to respiratory infections.

Debatable claims

• ▪Preclinical data is sufficient to justify public health warnings about vaping
• ▪Governments should regulate e-cigarettes as strictly as traditional tobacco